Product Description: SXC2023 is an inhibitor for solute carrier family 7 member 11 (SLC7A11). SXC2023 exhibits antitumor efficacy, and ameliorates central nervous system disorder through downregulation of glutamate export[1].
Applications: Cancer-programmed cell death
Formula: C13H15NO4S
References: [1]PENDERGAST AM, et al., Compositions and methods for the treatment cancer and cns disorders. WO2021030783 A1.